Decreasing readmissions through better discharge planning (DP) and transitional care is a national healthcare priority. RightCare Solutions has leveraged over 10 years of interdisciplinary academic research led by a nurse researcher, and through our highly successful phase one SBIR grant demonstrated market value for the D2S2 product and the technical expertise of our team. The D2S2 is a six-item decision support tool installed by RightCare Solutions in the hospital EHR to assist discharge planners to identify high-risk patients upon admission allowing time and focus to target appropriate transitional and post-acute care to prevent readmissions. We have achieved outstanding outcomes from our phase 1 award and are proposing further technological developments to enhance our commercial launch. The market potential for the D2S2 tool is significant since discharge decision support is estimated to be applicable to roughly 6,500 U.S. hospitals with a census that is 60% older adults equaling 14 million discharges per year. The phase 1 results indicate a significant impact on 30 and 60 day readmissions giving us strong evidence as to the value of the product. However, the results and our experience using the software indicate there is opportunity to enhance the product's accruacy and functionality. We propose to enhance our predictive accuracy through innovative data mining and machine learning techniques and to improve the functionality by electronically connecting the acute and post-acute care settings. Due to implementation in the three hospitals of the University of Pennsylvania Health System we have data on over 6,000 patients and through the continued live implementation we will accumulate data on over 25,000 patients by the start of the phase 2 grant. Using existing, and new data generated from continued operations, this proposed SBIR grant will advance the product in two major ways to enhance the commercial benefit to its users.
Aim 1 : Develop, test, and scale SMART capabilities, a dynamic process for improving prediction accuracy, by using hospital-specific and patient level characteristics (D2S2 variables and additional clinical and non-clinical characteristics) and modern data mining/machine learning techniques.
AIM 2 : Operationalize the D2S2 recommendations by electronically connecting high-risk patients with post-acute care (PAC) providers and stakeholders, known as CONNECT capabilities. Called a """"""""learning health system"""""""" the end- product of this SBIR grant will provide continuous evaluation and improvement to the end-user measured against their goals. Our innovative design produces a closed-loop system that will use data from the D2S2 and hospital databases over time to """"""""get smarter."""""""" Further, our enhanced product will link acute care to post-acute providers giving them advanced warning of patients who will shortly come to them for care.

Public Health Relevance

This decision support software identifies high-risk patients upon admission and alerts the clinicians in acute and post- acute care. This project will enhance the tool's SMART capabilities to improve its predictive accuracy and will CONNECT patients and providers with post-acute settings to coordinate the care transition.

Agency
National Institute of Health (NIH)
Institute
National Institute of Nursing Research (NINR)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
2R44NR013609-02
Application #
8710917
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Diana, Augusto
Project Start
2014-09-01
Project End
2016-08-31
Budget Start
2014-09-01
Budget End
2015-08-31
Support Year
2
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Rightcare Solutions, Inc.
Department
Type
DUNS #
City
Horsham
State
PA
Country
United States
Zip Code
19044
Bowles, Kathryn H; Heil, Eric (2014) From unmet clinical need to entrepreneurship: taking your informatics solution to market. Stud Health Technol Inform 201:315-20
Taylor, Natalie; Bahunde, Faith; Thompson, Afton et al. (2012) Enhanced priming of adaptive immunity by Mycobacterium smegmatis mutants with high-level protein secretion. Clin Vaccine Immunol 19:1416-25